Contact Research Now
Suppression of the Adaptive Immune Response Occurs Within 48 Hours of Sepsis for Critically Ill Children
Jennifer Muszynski, MD, principal investigator in the Center for Clinical and Translational Research, led a study on how adaptive immune suppression may be part of an early response to septic shock in critically ill pediatric patients.
Disruption of Bacterial Biofilms Offers New Therapeutic Approach for Disease Treatment, Study Shows
Lauren O. Bakaletz, PhD, director of the Center for Microbial Pathogenesis, and Steven D. Goodman, a principal investigator in the Center, have unveiled the mechanism by which antibodies disrupt bacterial biofilms, rendering them susceptible to antibiotics.